CNBC Cures: Acadia Pharmaceuticals CEO on scaling rare and neuro-focused drugs

Acadia Pharmaceuticals CEO Catherine Owen Adams joins 'Squawk Box' to discuss the company's focus on underserved neurological and rare disease patient communities, the company's relationship with the FDA, drug pipeline outlook, and more.